TSHA ▼ -2.7% - Taysha Gene Therapies, Inc. $TSHA - Taysha Gene Therapies Announces Multiple Encore Presentations Supporting TSHA-102 Rett Syndrome Clinical Program at the 55th Child Neurology Society Annual Meeting 01-OCT-2026 08:00 AM ET